Articles

In diabetes care, “therapeutic inertia” refers to the failure to escalate or modify treatment when a patient’s glucose control is suboptimal. Even now — when newer, more effective treatments and monitoring tools are widely available — therapeutic inertia in diabetes remains a stubborn barrier. Providers often wait too long before …

Starting insulin early in the course of type 2 diabetes may seem counter‑intuitive. After all, many patients and clinicians treat insulin as a “last resort.” Yet what if early insulin initiation could actually change the trajectory of the disease — preserving pancreatic function, improving long‑term control, and reducing complications? In …

Discover key strategies for preventing type 2 diabetes through healthy eating, regular exercise, weight management, and routine health screenings.

FDA approves once-weekly basal insulin, revolutionizing diabetes care with a more convenient and effective treatment for better glycemic control.

Explore the critical need for early intervention in type 2 diabetes to prevent severe complications and enhance quality of life.

Explore the new ADA guidelines advocating early combination therapy for Type 2 diabetes, aiming for improved patient outcomes and personalized care.

Discover why integrating podiatry into diabetes care is essential for preventing complications and enhancing patient well-being.

Discover groundbreaking 2025 trials reshaping cardiovascular outcomes in diabetes, highlighting new therapies and holistic care strategies.

Discover how GLP-1 drugs like Ozempic and Mounjaro are transforming diabetes care by enhancing glycemic control and reducing cardiovascular risks.

Discover how new drugs are transforming weight loss and diabetes management, setting new standards in care and improving patient outcomes.